Perrigo Company plc, a top five global over-the-counter (OTC) consumer goods and pharmaceutical company, offers consumers and customers high quality products at affordable prices. From its beginnings in 1887 as a packager of generic home remedies, Perrigo, headquartered in Ireland, has grown to become the world's largest manufacturer of OTC products and supplier of infant formulas for the store brand market. The Company is also a leading provider of branded OTC products, generic extended topical prescription products and receives royalties from Multiple Sclerosis drug Tysabri®. Perrigo provides “Quality Affordable Healthcare Products®” across a wide variety of product categories and geographies primarily in North America, Europe, and Australia, as well as other key markets including Israel and China.

Company Growth (employees)
Type
Public
HQ
Dublin, IE
Founded
1887
Size (employees)
13,300 (est)
Perrigo was founded in 1887 and is headquartered in Dublin, IE

Perrigo Office Locations

Perrigo has offices in Dublin and Allegan
Dublin, IE (HQ)
2 Lower Grand Canal St
Allegan, US
515 Eastern Ave

Perrigo Metrics

Perrigo Financial Metrics

Revenue (2015)

$4.6 b

Revenue growth (2014-15), %

13%

Gross profit

$1.7 b

Gross profit margin (2015), %

37%

Net income (2015)

$128 m

Market capitalization (28-Apr-2017)

$10.6 b

Closing share price (28-Apr-2017)

$74

Cash (27-Jun-2015)

$785.6 m
Perrigo's current market capitalization is $10.6 b.
Perrigo's revenue was reported to be $4.6 b in FY, 2015 which is a 13% increase from the previous period.
FY, 2014FY, 2015

Revenue

$4.1 b$4.6 b

Revenue growth, %

13%

Cost of goods sold

$2.9 b

Gross profit

$1.7 b

Gross profit Margin, %

37%

Operating expense total

$964.8 m

EBIT

$747.7 m

EBIT margin, %

16%

Interest expense

$146 m

Income tax expense

$120 m

Net Income

($205.3 m)$128 m
FY, 2014FY, 2015

Cash

$799.5 m$785.6 m

Accounts Receivable

$935.1 m$1.3 b

Inventories

$631.6 m$838.9 m

Current Assets

$2.6 b$3.2 b

PP&E

$932.4 m

Total Assets

$13.9 b$19.7 b

Accounts Payable

$364.3 m$747.5 m

Current Liabilities

$1.1 b$1.7 b

Non-Current Liabilities

$4.1 b$7.4 b

Total Liabilities

$5.2 b$9.1 b

Retained Earnings

$1.9 b$1.9 b

Total Equity

$8.7 b$10.7 b

Financial Leverage

1.6 x1.8 x
FY, 2014FY, 2015

Net Income

($205.3 m)$128 m

Depreciation and Amortization

$358.9 m$548.8 m

Accounts Receivable

($230 m)($82 m)

Inventories

$83 m$10.7 m

Accounts Payable

($24.9 m)$140.6 m

Cash From Operating Activities

$693.5 m$1.2 b

Purchases of PP&E

($171.6 m)($137 m)

Long-term Borrowings

($2 b)($1.8 b)

Interest Paid

$98.4 m$143.2 m

Income Taxes Paid

$93.2 m$131 m

Perrigo Market Value History

Perrigo Median Salaries

Source: 11 public H-1B filings from Perrigo

Perrigo Online Presence

Perrigo News

Perrigo Company Life

You may also be interested in